The Burden of Respiratory Syncytial Virus in Children Under 2 Years of Age in a Rural Community in Maharashtra, India.
community
epidemiology
morbidity
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
02 09 2021
02 09 2021
Historique:
entrez:
2
9
2021
pubmed:
3
9
2021
medline:
8
10
2021
Statut:
ppublish
Résumé
Globally, respiratory syncytial virus (RSV) is a common cause of acute lower tract infection (LRTI) in children younger than 2 years of age, but there are scant population-based studies on the burden of RSV illness in rural communities and no community studies in preterm infants. Active surveillance of LRTI was performed in the community and hospital setting for the population of 93 tribal villages in Melghat, Central India, over 4 respiratory seasons. A nasopharyngeal swab was obtained from cases presenting as a severe LRTI for molecular analysis of respiratory pathogens including RSVA and B. High rates of RSV-associated LRTI were found in preterm and term infants beyond 6 months of age, extending into the second year of life. Community severe RSV LRTI rates for 0-11 months of age was 22.4 (18.6-27.0)/1000 child-years (CY) and the hospital-associated rate was 14.1 (11.1-17.8)/1000 CY. For preterm infants, these rates were 26.2 (17.8-38.5)/1000 CY and 12.6 (7.2-22.0)/1000 CY. Comparable rates in the first 6 months were 15.9 (11.8-21.4)/1000 CY and 12.9 (9.3-18.0)/1000 CY in term infants and 26.3 (15.4-45.0)/1000 CY and 10.1 (4.2-24.2)/1000 CY for preterms. The single RSV B season had higher incidences of RSV LRTI in every age group than the 2 RSV A seasons in both preterm and term infants. There were 11 deaths, all term infants. Studies restricted to the healthcare settings significantly underestimate the burden of RSV LRTI and preterm and term infants have comparable burdens of disease in this rural community.
Sections du résumé
BACKGROUND
Globally, respiratory syncytial virus (RSV) is a common cause of acute lower tract infection (LRTI) in children younger than 2 years of age, but there are scant population-based studies on the burden of RSV illness in rural communities and no community studies in preterm infants.
METHODS
Active surveillance of LRTI was performed in the community and hospital setting for the population of 93 tribal villages in Melghat, Central India, over 4 respiratory seasons. A nasopharyngeal swab was obtained from cases presenting as a severe LRTI for molecular analysis of respiratory pathogens including RSVA and B.
RESULTS
High rates of RSV-associated LRTI were found in preterm and term infants beyond 6 months of age, extending into the second year of life. Community severe RSV LRTI rates for 0-11 months of age was 22.4 (18.6-27.0)/1000 child-years (CY) and the hospital-associated rate was 14.1 (11.1-17.8)/1000 CY. For preterm infants, these rates were 26.2 (17.8-38.5)/1000 CY and 12.6 (7.2-22.0)/1000 CY. Comparable rates in the first 6 months were 15.9 (11.8-21.4)/1000 CY and 12.9 (9.3-18.0)/1000 CY in term infants and 26.3 (15.4-45.0)/1000 CY and 10.1 (4.2-24.2)/1000 CY for preterms. The single RSV B season had higher incidences of RSV LRTI in every age group than the 2 RSV A seasons in both preterm and term infants. There were 11 deaths, all term infants.
CONCLUSIONS
Studies restricted to the healthcare settings significantly underestimate the burden of RSV LRTI and preterm and term infants have comparable burdens of disease in this rural community.
Identifiants
pubmed: 34472575
pii: 6362481
doi: 10.1093/cid/ciab508
pmc: PMC8411254
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
S238-S247Subventions
Organisme : Bill and Melinda Gates Foundation
ID : OPP1128468
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
Am J Trop Med Hyg. 2014 Nov;91(5):1029-34
pubmed: 25294617
J Infect Dis. 2013 Dec 15;208 Suppl 3:S189-96
pubmed: 24265478
J Infect Dis. 2014 Jun 1;209(11):1685-92
pubmed: 24367040
J Infect Dis. 2020 Dec 21;:
pubmed: 33346360
Infect Dis Ther. 2016 Dec;5(4):417-452
pubmed: 27628014
Pediatrics. 2011 Jan;127(1):35-41
pubmed: 21187309
Am J Respir Crit Care Med. 2017 Jan 1;195(1):96-103
pubmed: 27331632
J Pediatr. 2012 May;160(5):827-31.e1
pubmed: 22177993
Pediatr Infect Dis J. 2011 Sep;30(9):778-84
pubmed: 21487330
Clin Infect Dis. 2020 May 6;70(10):2029-2035
pubmed: 31257406
Infect Dis Ther. 2016 Dec;5(4):453-471
pubmed: 27864751
Indian J Med Res. 2018 Sep;148(3):329-333
pubmed: 30425224
Curr Top Microbiol Immunol. 2013;372:39-57
pubmed: 24362683
Lancet Glob Health. 2019 Jan;7(1):e37-e46
pubmed: 30389451
PLoS One. 2015 Jun 24;10(6):e0130233
pubmed: 26107630
Front Immunol. 2019 May 07;10:1006
pubmed: 31134078
Am J Epidemiol. 2012 Nov 1;176(9):794-802
pubmed: 23059788
Bull World Health Organ. 2004 Dec;82(12):914-22
pubmed: 15654405
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
Infect Dis Ther. 2017 Sep;6(3):383-411
pubmed: 28653300
N Engl J Med. 1993 Nov 18;329(21):1524-30
pubmed: 8413475
Infect Dis Ther. 2017 Mar;6(1):37-56
pubmed: 28070870
Pediatrics. 1998 Sep;102(3 Pt 1):531-7
pubmed: 9738173
Pediatr Infect Dis J. 2003 Feb;22(2):150-7
pubmed: 12586979
Eur J Pediatr. 2021 Jul;180(7):2125-2135
pubmed: 33634335
Clin Infect Dis. 2012 Mar;54(6):810-7
pubmed: 22247121
PLoS One. 2012;7(2):e32056
pubmed: 22384139
Pediatr Pulmonol. 2017 Apr;52(4):556-569
pubmed: 27740723
Infect Dis Ther. 2016 Sep;5(3):271-98
pubmed: 27480325